Robert J. Brown, M.D. has served as Executive Vice President of Clinical Development since January 2022, and served as the company’s Senior Vice President of Clinical Development from January through December 2021 and Vice President of Clinical Development from June through December 2020. He is trained as a pediatric neuro-oncologist with a decade of immunotherapy drug development expertise. Prior to joining Nurix, Dr. Brown led cellular therapy development programs in both solid tumors and hematologic malignancies, including allogeneic CAR-T cells at Allogene and tumor infiltrating lymphocytes at Iovance Biotherapeutics. Dr. Brown’s training includes pediatric oncology at the Yale School of Medicine and the treatment of pediatric brain and spinal cord tumors at Children’s Hospital Los Angeles and University of Southern California. He completed a postdoctoral fellowship in radiation-induced brain injury at UCLA, focusing on the role of long-term inflammation on brain development, repair, and dementia. He holds a B.Sc. in chemistry from the Massachusetts Institute of Technology and an M.D. from the Weill Cornell Medical College in New York.